Coeptis CSO/CMO Colleen Delaney resigns effective March 24; will consult up to 6 months

Z Squared Inc.

Colleen Delaney resigned as Chief Scientific and Medical Officer, effective March 24, 2025.
She joined in August 2023 and is leaving to pursue another business opportunity.
Delaney will provide transition consulting services for up to six months.
No successor has been announced at this time.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Colleen Delaney

Chief Scientific and Medical Officer

ZSQR · Z Squared Inc.

Effective: 2025-03-24
Filed: March 27, 2025, 7:59 PM ET

On March 21, 2025, Colleen Delaney submitted her resignation from her role as Chief Scientific and Medical Officer of the Coeptis Therapeutics Holdings, Inc. (the “Company”), effective March 24, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Colleen Delaney resigned as Chief Scientific and Medical Officer at Z Squared Inc..

Action: resigned
Role: Chief Scientific and Medical Officer

Exact text from the filing

On March 21, 2025, Colleen Delaney submitted her resignation from her role as Chief Scientific and Medical Officer of the Coeptis Therapeutics Holdings, Inc. (the “Company”), effective March 24, 2025.

View on SEC.gov

Z Squared Inc. filing history →

Source: SEC EDGAR

accession 0001683168-25-001940

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.